InNexus Biotechnology (InNexus Biotechnology) Tangible Book per Share : $-0.06 (As of Mar. 2011)

InNexus Biotechnology Tangible Book per Share Chart

InNexus Biotechnology Annual Data
	Trend	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07	Jun08	Jun09	Jun10
Tangible Book per Share		Get a 7-Day Free Trial					0.01	0.09	0.06	-0.06	-0.06

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Tangible Book per Share	Get a 7-Day Free Trial															-0.06	-0.06	-0.06	-0.05	-0.06

Competitive Comparison of InNexus Biotechnology's Tangible Book per Share

For the Biotechnology subindustry, InNexus Biotechnology's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InNexus Biotechnology's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InNexus Biotechnology's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where InNexus Biotechnology's Price-to-Tangible-Book falls into.

InNexus Biotechnology Tangible Book per Share Calculation

InNexus Biotechnology's Tangible Book Value Per Share for the fiscal year that ended in Jun. 2010 is calculated as

InNexus Biotechnology's Tangible Book Value Per Share for the quarter that ended in Mar. 2011 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total equity is a balance sheet item and equal to total assets less total liabilities of the company. Since intangibles such as goodwill cannot be sold when the company liquidates, tangible book value per share is considered more accurate in reflecting how much shareholders will receive when the company liquidates.

InNexus Biotechnology  (GREY:IXSBF) Tangible Book per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

InNexus Biotechnology Tangible Book per Share Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Tangible Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description